SEC Comment Letter 0000000000-24-011780 to VACCINEX, INC. (VCNX) (CIK 0001205922) (VCNX)
VACCINEX, INC. (VCNX) (CIK 0001205922)
Date: Oct. 21, 2024 · CIK: 0001205922 · Accession: 0000000000-24-011780
AI Filing Summary & Sentiment
File numbers found in text: 333-282679
Letter
October 21, 2024 Maurice Zauderer Chief Executive Officer Vaccinex, Inc. 1895 Mount Hope Avenue Rochester, NY 14620 Re:Vaccinex, Inc. Registration Statement on Form S-3 Filed October 16, 2024 File No. 333-282679 Dear Maurice Zauderer: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tyler Howes at 202-551-3370 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:William I. Intner, Esq.
Show Raw Text
October 21, 2024
Maurice Zauderer
Chief Executive Officer
Vaccinex, Inc.
1895 Mount Hope Avenue
Rochester, NY 14620
Re:Vaccinex, Inc.
Registration Statement on Form S-3
Filed October 16, 2024
File No. 333-282679
Dear Maurice Zauderer:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tyler Howes at 202-551-3370 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:William I. Intner, Esq.